B
Brian Godman
Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences
Publications - 584
Citations - 13892
Brian Godman is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 52, co-authored 483 publications receiving 10286 citations. Previous affiliations of Brian Godman include Karolinska University Hospital & Mario Negri Institute for Pharmacological Research.
Papers
More filters
Journal ArticleDOI
Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study.
Johanna C Meyer,Natalie Schellack,Jacobus Stokes,Ruth Lancaster,Helecine Zeeman,Douglas Defty,Brian Godman,Gavin Steel +7 more
TL;DR: Overall, there are an appreciable number of ongoing activities within the public healthcare system in South Africa attempting to ensure and sustain universal healthcare.
Journal ArticleDOI
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Jakub Adamski,Brian Godman,Brian Godman,Brian Godman,Gabriella Ofierska-Sujkowska,Bogusława Osińska,Harald Herholz,Kamila Wendykowska,Ott Laius,Saira Jan,Catherine Sermet,Corrine Zara,Marija Kalaba,Roland Gustafsson,Kristina Garuoliene,Alan Haycox,Silvio Garattini,Lars L. Gustafsson +17 more
TL;DR: There are only a limited number of situations where 'risk sharing' schemes should be considered as well as factors thatShould be considered by payers in advance of implementation, and whether systematic evaluations have been built into proposed schemes.
Journal ArticleDOI
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Lars L. Gustafsson,Björn Wettermark,Björn Wettermark,Brian Godman,Eva Andersén-Karlsson,Ulf Bergman,Jan Hasselström,Lars-Olof Hensjö,Paul Hjemdahl,Ingrid Jägre,Margaretha Julander,Bo Ringertz,Daniel Schmidt,Susan Sjöberg,Folke Sjöqvist,Carl-Olav Stiller,Elisabeth Törnqvist,Rolf Tryselius,Sigurd Vitols,Christer von Bahr +19 more
TL;DR: The acceptance of the 'Wise List' in terms of trust among physicians and among the public and increased adherence may be explained by clear criteria for drug recommendations, a comprehensive communication strategy, electronic access to recommendations, continuous medical education and involvement of professional networks and patients.
Journal ArticleDOI
Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Bráulio Cezar Bonoto,Vânia Eloisa de Araújo,Isabella Piassi Godói,Lívia Lovato Pires de Lemos,Brian Godman,Marion Bennie,Leonardo Maurício Diniz,Augusto Afonso Guerra Junior +7 more
TL;DR: The use of apps by diabetic patients could help improve the control of HbA1c and seem to strengthen the perception of self-care by contributing better information and health education to patients.
Journal ArticleDOI
Policies for biosimilar uptake in Europe: An overview.
Evelien Moorkens,Arnold G. Vulto,Isabelle Huys,Pieter Dylst,Brian Godman,Brian Godman,Simon Keuerleber,Barbara Claus,Maria Dimitrova,Guenka Petrova,Ljiljana Sović-Brkičić,Juraj Slabý,Robin Šebesta,Ott Laius,Allan Karr,Morgane Beck,Jaana E. Martikainen,Gisbert Selke,Susan Spillane,Laura McCullagh,Gianluca Trifirò,Patricia Vella Bonanno,Asbjørn Mack,Antra Fogele,Anita Viksna,Magdalena Władysiuk,Helder Mota-Filipe,Dmitry Meshkov,Marija Kalaba,Simona Mencej Bedrač,Jurij Fürst,Corrine Zara,Peter Skiold,Einar Magnusson,Steven Simoens +34 more
TL;DR: Most countries have put in place specific supply-side policies for promoting access to biosimilars, but investments should be made to clearly communicate on biosimilarars and educate stakeholders to support a sustainable biosimilar market.